Adverse events105

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 105

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Fatigue	General disorders	Azilsartan Medoxomil 20-40mg/Chlorthalidone 12.5-25mg QD	33	355
other	Fatigue	General disorders	Azilsartan Medoxomil 40-80mg/Chlorthalidone 12.5-25mg QD	14	352
other	Fatigue	General disorders	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	16	364
other	Blood creatinine increased	Investigations	Azilsartan Medoxomil 20-40mg/Chlorthalidone 12.5-25mg QD	66	355
other	Blood creatinine increased	Investigations	Azilsartan Medoxomil 40-80mg/Chlorthalidone 12.5-25mg QD	78	352
other	Blood creatinine increased	Investigations	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	34	364
other	Blood uric acid increased	Investigations	Azilsartan Medoxomil 20-40mg/Chlorthalidone 12.5-25mg QD	19	355
other	Blood uric acid increased	Investigations	Azilsartan Medoxomil 40-80mg/Chlorthalidone 12.5-25mg QD	17	352
other	Blood uric acid increased	Investigations	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	12	364
other	Dizziness	Nervous system disorders	Azilsartan Medoxomil 20-40mg/Chlorthalidone 12.5-25mg QD	41	355
other	Dizziness	Nervous system disorders	Azilsartan Medoxomil 40-80mg/Chlorthalidone 12.5-25mg QD	58	352
other	Dizziness	Nervous system disorders	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	29	364
other	Headache	Nervous system disorders	Azilsartan Medoxomil 20-40mg/Chlorthalidone 12.5-25mg QD	19	355
other	Headache	Nervous system disorders	Azilsartan Medoxomil 40-80mg/Chlorthalidone 12.5-25mg QD	13	352
other	Headache	Nervous system disorders	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	26	364
serious	Anaemia	Blood and lymphatic system disorders	Azilsartan Medoxomil 20-40mg/Chlorthalidone 12.5-25mg QD	0	355
serious	Anaemia	Blood and lymphatic system disorders	Azilsartan Medoxomil 40-80mg/Chlorthalidone 12.5-25mg QD	1	352
serious	Anaemia	Blood and lymphatic system disorders	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	0	364
serious	Arrhythmia	Cardiac disorders	Azilsartan Medoxomil 20-40mg/Chlorthalidone 12.5-25mg QD	0	355
serious	Arrhythmia	Cardiac disorders	Azilsartan Medoxomil 40-80mg/Chlorthalidone 12.5-25mg QD	1	352

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01033071/events

API reference For AI assistants

Adverse events105

Sources 3

Read this list from software.